CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Australia
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Australia. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Australia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and inhouse analysis by GlobalData's team of industry experts.
Australia has one of the fastest growing pharmaceutical markets in the world, providing safe and affordable health care to its citizen. The pharmaceutical market in Australia was valued at $10.58B in 2011 and increased at CAGR of 3.3% to $11.69B in 2018. The market is expected to reach $13.33B in 2022. However, the market value in terms of Australian Dollar was AUD$10.26B in 2011 and increased at a CAGR of 6% to AUD$15.65B in 2018. It is expected to reach AUD$19.78B in 2022. The difference is due to currency exchange fluctuations. In 2015, the medical device market in Australia was worth $8.4B, which increased to $9.5B in 2018 at a CAGR of 4.2%. It is expected to reach $11.9B in 2023. The Australian healthcare market is driven by universal healthcare coverage, wide access to governmentsubsidized medicine, growing elderly population and its associated disease burden, welldefined regulatory guidelines, the usage of substitute drugs and the introduction of a new manufacturing policy.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Australia, and includes
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market Sanofi, Pfizer, Astrazeneca, GSK, and Clinuvel and profiles and SWOT analyses of the major players in the medical device market Medtronic, Abbott, Siemens, Stryker, and Zimmer Biomet
Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Australia
Porter's five forces analysis for pharmaceutical and medical devices market of Australia
An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
Information regarding the healthtech landscape of the country along with the major healthtech deals
Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
An overview of the opportunities and challenges to growth in the Australian healthcare market
Reasons to buy
This report will enhance your decisionmaking capability by allowing you to
Develop business strategies by understanding the trends shaping and driving the Australian healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Identify, understand, and capitalize on the opportunities and challenges in the Australian healthcare market